Vaccine Hesitancy at Nine Community Sites Across the United States, Early in Covid-19 Vaccine Rollout

Datos Bibliográficos

ID2073486
AutoresAneeka Ratnayake (0000-0001-8955-8665, Tulane University, autor de correspondencia), Julie H Hernandez (0000-0002-0868-0958, Tulane University), Jessica Justman (0000-0003-4704-3115, Aaron Diamond AIDS Research Center), Jason E Farley (0000-0002-6896-0134, Johns Hopkins University), Yael Hirsch-Moverman, Yael Hirsch‐Moverman (0000-0003-0096-1306, ICAP Global Health), Ken H M Ho (0000-0003-4934-2450, University of Pittsburgh), Ken Ho (0000-0001-7973-1268), Stockton Mayer (0000-0002-0647-8000, Illinois College), Abiodun Oluyomi (0000-0002-6603-6941, Baylor College of Medicine), Magdalena E Sobieszczyk (0000-0002-7112-3118, Aaron Diamond AIDS Research Center), Shobha Swaminathan (0000-0002-5087-1037, Rutgers, the State University of New Jersey), Timothy Skalland (0000-0001-8317-7685, Fred Hutch Cancer Center), Jean De Dieu Tapsoba (0000-0001-7453-4329, Fred Hutch Cancer Center), The Covpn Study Team, Patricia J Kissinger (Tulane University)
Año2024
Volumen12
Número6
Páginas3721-3732
Fecha de publicación2024-09-12
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Racial and Ethnic Health Disparities (JOURNAL)
Identificadores de la revistaISSN: 2196-8837 • E-ISSN: 2197-3792
EditorialSpringer Science and Business Media LLC (PUBLISHER)
DOI10.1007/s40615-024-02172-0
PMID39264541
OpenAlexW4402481292
IdiomaEN
Referencias citadas46

Background Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy. Methods Between January and July 2021, potential participants were recruited from community venues selected through time-location sampling in 15 defined communities in the United States. Study staff administered a questionnaire on demographics, COVID-19 behaviors and attitudes, and vaccination status or intention to consenting individuals. Vaccine hesitancy was analyzed among those age 18 years and older from nine of the 15 sites and was defined as self-reported neutral, unlikely, or very unlikely vaccine intention. Logistic regression modeling, adjusted for site, identified factors associated with vaccine hesitancy. Results Among 11,559 individuals, vaccine hesitancy by site ranged from 8.7 to 31.1%. Vaccine hesitancy was associated with being Black compared to White, being White compared to Asian, younger age, unstable housing, being unemployed, lower income, having a disability, providing care in home, not reporting inability to visit sick or elderly relatives during the pandemic, not reporting increased anxiety during the pandemic, and not spending more time with loved ones during the pandemic. Conclusions In these selected US communities, early in vaccine rollout, there were significant racial disparities in vaccine hesitancy. Additionally, individuals who were more marginalized due to their socioeconomic status were more likely to report vaccine hesitancy. Vaccine campaigns should make efforts to remove barriers to vaccination, by improving convenience

Coronavirus disease 2019 (COVID-19 · Demographics · Disease · Environmental health · Ethnic group · Family medicine · Infectious disease (medical specialty · Logistic regression · Pandemic · Political science · Population · Public health · Socioeconomic status · Vaccination · Demography · Medicine · Misinformation and Its Impacts · Nursing · Psychology of Moral and Emotional Judgment · Vaccine Coverage and Hesitancy · Gerontology · Immunology